| Bioactivity | Draflazine (R-75231) is a ENT1 inhibitor. Draflazine (R-75231) completely reverses the hypersensitivity in the complete Freund’s adjuvant (CFA) model of mechanical hyperalgesia and the carrageenan inflammation model of thermal and mechanical hyperalgesia[1]. |
| Target | ENT1 |
| Name | Draflazine |
| CAS | 120770-34-5 |
| Formula | C30H33Cl2F2N5O2 |
| Molar Mass | 604.52 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Maes SS, et al. Antihyperalgesic activity of nucleoside transport inhibitors in models of inflammatory pain in guinea pigs. J Pain Res. 2012;5:391-400. |
Draflazine
CAS: 120770-34-5 F: C30H33Cl2F2N5O2 W: 604.52
Draflazine (R-75231) is a ENT1 inhibitor. Draflazine (R-75231) completely reverses the hypersensitivity in the complete
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.